US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Pharmaceuticals Company Reports Market Research Reports & Industry Analysis

RSS Feeds

Pharmaceuticals Company Reports Industry Research & Market Reports

1  2  3    5    7  8  9  10  
Merck: Strategic Direction, Marketing Tactics and Technological Know-How in the Global Animal Health Market
7/14/2016 | published by: VPGMarketResearch.com
... to business survival, growth and profitability. This new report from VPGMarketResearch.com provides strategic assessment of Merck's technological know-how, marketing tactics and strategic directions in the global animal health market. SECTION I: TECHNOLOGICAL KNOW-HOW SECTION II: ...  |  read more...
USD 750
Zoetis: Strategic Direction, Marketing Tactics and Technological Know-How in the Global Animal Health Market
7/14/2016 | published by: VPGMarketResearch.com
... to business survival, growth and profitability. This new report from VPGMarketResearch.com provides strategic assessment of Zoetis' technological know-how, marketing tactics and strategic directions in the global animal health market. SECTION I: TECHNOLOGICAL KNOW-HOW SECTION II: ...  |  read more...
USD 750
Mead Johnson Nutrition Company (MJN) - Financial and Strategic SWOT Analysis Review
6/1/2016 | published by: GlobalData
... bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you ...  |  read more...
USD 125
Arbutus Biopharma Corporation - Product Pipeline Review - 2016
6/30/2016 | published by: Global Markets Direct
... focus. The report provides comprehensive information on the therapeutics under development by Arbutus Biopharma Corporation, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. ...  |  read more...
USD 1,500
Global Merger and Acquisition Terms and Agreements in Pharma, Biotech and Diagnostics 2010-2016
6/1/2016 | published by: Current Partnering
... and acquisition (M&A) agreements announced in the pharmaceutical, biotechnology, diagnostic and other lifescience sectors. Fully revised and updated, the report provides details of M&A agreements from 2010 to 2016. The report provides a detailed understanding ...  |  read more...
USD 2,995
Zyngenia Inc.
6/13/2016 | published by: PrivCo
... competitors or competitive position / products / services, Zyngenia Inc. founders, and more private company information on Zyngenia Inc. Zyngenia Inc. summary: Founded in 2008, Zyngenia, Inc. is a privately held biotherapeutics company focused on ...  |  read more...
USD 225
Ra Pharmaceuticals
6/13/2016 | published by: PrivCo
This PrivCo private company report on Ra Pharmaceuticals provides a detailed Ra Pharmaceuticals company profile, consisting of and more private company information on Ra Pharmaceuticals  |  read more...
USD 225
Ferring Pharmaceuticals Limited
6/13/2016 | published by: PrivCo
... private company information on Ferring Pharmaceuticals Limited Ferring Pharmaceuticals Limited summary: Ferring Pharmaceuticals Limited is a privately-held company that operates in the wholesale distribution industry. Ferring Pharmaceuticals Limited headquarters are located in West Drayton Ward, ...  |  read more...
USD 225
Astellas Pharma Inc. - Product Pipeline Review - 2016
5/31/2016 | published by: Global Markets Direct
... focus. The report provides comprehensive information on the therapeutics under development by Astellas Pharma Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. ...  |  read more...
USD 1,500
Arno Therapeutics, Inc. (ARNI) - Financial and Strategic SWOT Analysis Review
6/21/2016 | published by: GlobalData
... to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to ...  |  read more...
USD 125
Chemical Company of Malaysia Berhad (CCM) - Financial and Strategic SWOT Analysis Review
6/28/2016 | published by: GlobalData
... to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling ...  |  read more...
USD 125
Chugai Pharmaceutical Co., Ltd. (4519) - Financial and Strategic SWOT Analysis Review
6/21/2016 | published by: GlobalData
... bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you ...  |  read more...
USD 125
inVentiv Health, Inc. - Strategic SWOT Analysis Review
6/21/2016 | published by: GlobalData
... key employees, key competitors and major products and services. This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better. Scope ...  |  read more...
USD 300
Juniper Pharmaceuticals, Inc. (JNP) - Financial and Strategic SWOT Analysis Review
6/21/2016 | published by: GlobalData
... to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to ...  |  read more...
USD 125
Navamedic ASA (NAVA) - Financial and Strategic SWOT Analysis Review
6/28/2016 | published by: GlobalData
... you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand ...  |  read more...
USD 125
Purdue Pharma L.P. - Strategic SWOT Analysis Review
6/21/2016 | published by: GlobalData
... key employees, key competitors and major products and services. This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better. Scope ...  |  read more...
USD 125
Taro Pharmaceutical Industries Ltd. (TARO) - Financial and Strategic SWOT Analysis Review
6/28/2016 | published by: GlobalData
... bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you ...  |  read more...
USD 125
Grifols – Clayton Industrial Complex Expansion: Plasma Fractionation Plant – North Carolina - Construction Project Profile
7/9/2016 | published by: Timetric
... information on the scope of the project including project overview and location. The profile also details project ownership and funding, gives a full project description, as well as information on contracts, tendering and key project ...  |  read more...
USD 75
Global Cardiovascular Partnering 2010-2016: Deal trends, players and financials
7/1/2016 | published by: Current Partnering
... in Cardiovascular partnering deals Financial deal terms for headline, upfront and royalty by stage of development Cardiovascular partnering agreement structure Cardiovascular partnering contract documents Top Cardiovascular deals by value Most active Cardiovascular dealmakers Most of ...  |  read more...
USD 2,995
Global Gastrointestinal Partnering 2010-2016: Deal trends, players and financials
7/1/2016 | published by: Current Partnering
... in Gastrointestinal partnering deals Financial deal terms for headline, upfront and royalty by stage of development Gastrointestinal partnering agreement structure Gastrointestinal partnering contract documents Top Gastrointestinal deals by value Most active Gastrointestinal dealmakers Most of ...  |  read more...
USD 2,995
Global Genetic disorders Partnering 2010-2016: Deal trends, players and financials
7/1/2016 | published by: Current Partnering
... since 2010. Trends in Genetic Disorders partnering deals Financial deal terms for headline, upfront and royalty by stage of development Genetic Disorders partnering agreement structure Genetic Disorders partnering contract documents Top Genetic Disorders deals by ...  |  read more...
USD 2,995
Global Immunology Partnering 2010-2016: Deal trends, players and financials
7/1/2016 | published by: Current Partnering
... in Immunology partnering deals Financial deal terms for headline, upfront and royalty by stage of development Immunology partnering agreement structure Immunology partnering contract documents Top Immunology deals by value Most active Immunology dealmakers Most of ...  |  read more...
USD 2,995
Global Viral Partnering 2010-2016: Deal trends, players and financials
7/1/2016 | published by: Current Partnering
... in Viral partnering deals Financial deal terms for headline, upfront and royalty by stage of development Viral partnering agreement structure Viral partnering contract documents Top Viral deals by value Most active Viral dealmakers Most of ...  |  read more...
USD 2,995
Global Psychiatry Partnering 2010-2016: Deal trends, players and financials
7/1/2016 | published by: Current Partnering
... in Psychiatry partnering deals Financial deal terms for headline, upfront and royalty by stage of development Psychiatry partnering agreement structure Psychiatry partnering contract documents Top Psychiatry deals by value Most active Psychiatry dealmakers Most of ...  |  read more...
USD 2,995
Global Respiratory Partnering 2010-2016: Deal trends, players and financials
7/1/2016 | published by: Current Partnering
... in Respiratory partnering deals Financial deal terms for headline, upfront and royalty by stage of development Respiratory partnering agreement structure Respiratory partnering contract documents Top Respiratory deals by value Most active Respiratory dealmakers Most of ...  |  read more...
USD 2,995
1  2  3    5    7  8  9  10